Anavex Life Sciences Corp (AVXL)

[blu_1]

McMagyar, for weeks you talked about the guaranteed mind blowing monotherapy results that would be revealed at CTAD. FYI, there was no mention of scores for the monotherapy subgroup at CTAD. They weren't segregated out if you'll recall. So we don't even know how they did post 31 weeks. It is very easy for a tiny subgroup (n=7) to register unexpected results, to the good, or the bad. You really expect main stream media to get worked up into a frenzy based on just 7 patients results at 31 weeks in an early, exploratory Ph 2A trial outside the USA that lacks a placebo control?